Exelixis and Genentech Forge R&D Pact
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 61 (Table of Contents)
Published: 5 Jul-2005
DOI: 10.3833/pdr.v2005.i61.652 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Exelixis entered into an agreement with Genetech for the discovery and development of therapeutics that target the Notch pathway for the treatment of cancer, inflammatory diseases and tissue growth and repair...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS